
- /
- Supported exchanges
- / US
- / ADMA.NASDAQ
ADMA Biologics Inc (ADMA NASDAQ) stock market data APIs
ADMA Biologics Inc Financial Data Overview
ADMA Biologics, Inc., a biopharmaceutical company, develops, manufactures, and markets specialty plasma-derived biologics for the treatment of immune deficiencies and infectious diseases in the United States and internationally. The company offers BIVIGAM, an intravenous immune globulin (IVIG) product indicated for the treatment of primary humoral immunodeficiency (PI); ASCENIV, an IVIG product for the treatment of PI; and Nabi-HB, a human polyclonal antibody product for the treatment of acute exposure to blood containing Hepatitis B surface antigen and other listed exposures to Hepatitis B. It also develops a pipeline of plasma-derived therapeutics comprising products related to the methods of treatment and prevention of S. pneumonia infection for an immunoglobulin. In addition, the company operates source plasma collection facilities. The company sells its products through independent distributors, drug wholesalers, specialty pharmacies, and other alternate site providers. ADMA Biologics, Inc. was incorporated in 2004 and is headquartered in Ramsey, New Jersey.
* We provide hundreds of fields of fundamental data, including EBITDA, P/E ratio, PEG ratio, trailing P/E, shareholders, insider transactions, technical metrics, dividends, splits, earnings, and more. Check out our Fundamental Data API.
ETFs with ADMA Biologics Inc (top by weight)
* We provide detailed information about ETF constituents through our Fundamentals API for ETFs. Read the documentation to learn more.
Why to choose EODHD?
Prices start at $19.99
24/7 Live support
Robust, powerful and reliable data
API Simplicity of a few lines of code
Or get access to advanced financial data starting only $19.99
Get ADMA Biologics Inc data using free add-ons & libraries
Get ADMA Biologics Inc Fundamental Data
ADMA Biologics Inc Fundamental data includes:
- Net Revenue: 474 M
- EBITDA: 164 M
- Earnings Per Share:
- Income Statements
- Balance Sheets
- Cash flows
Plans with Fundamental data
Starting from
End-of-day & Earnings data
What’s included:
- Latest Release: 2025-08-06
- EPS/Forecast: 0.15
What’s included:
- End of Day, Intraday and Live APIs
- Splits
- Dividends
ADMA Biologics Inc News

Here's Why Adma Biologics (ADMA) Fell More Than Broader Market
Adma Biologics (ADMA) ended the recent trading session at $14.56, demonstrating a -3.51% change from the preceding day's closing price. The stock's change was less than the S&P 500's daily loss of 0.6...


US High Growth Tech Stocks To Watch For Potential Expansion
Amid a backdrop of fluctuating indices and geopolitical uncertainties, the U.S. market has seen tech-heavy Nasdaq and the S&P 500 experience slight declines as investors process a wave of earnings rep...

Exploring 3 High Growth Tech Stocks in the US Market
In a volatile trading session, major U.S. stock indexes ended mostly higher as robust bank earnings and strong performances in the tech sector helped lift market sentiment, despite ongoing concerns ab...

High Growth US Tech Stocks To Watch In October 2025
As of October 2025, the U.S. stock market has been experiencing significant volatility, with major indices like the Nasdaq and S&P 500 rebounding sharply after recent declines due to geopolitical tens...
Or get access to advanced financial data starting only $19.99
- Flexibility: No long-term commitments, just a minimum of one month
- Instant access: Get your API key and instructions within seconds of subscribing
- Price stability: Locked-in rates for subscribed users, never changing
What’s included:
- API Calls per Day: 100 000/day
- API Requests per Min.: 1000/minute
- Type of Usage: Personal use
Data access:
Historical EOD, Fundamental, Real-Time, Intraday, Live (Delayed), Technical & Screener APIs, News Feed, 40 000 Stock Logos and many more. See a full list.